SQI Diagnostics Inc V.SQD.H

Alternate Symbol(s): SQIDF

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > XBB.1.16

<< Previous

Bullboard Posts

Next >>

Post by FactFinder1994on Mar 18, 2023 2:34pm

174 Views

Post# 35346924

XBB.1.16

"All eyes should be on India! If XBB.1.16 aka #Arcturus could succeed to wade through the 'sturdy' population immunity of Indians that successfully resisted the onslaught of variants like BA.2.75, BA.5, BQs, XBB.1.5, then whole world must be seriously worried!!" Vipin M Vashishtha, former convenor of Indian Academy of Pediatrics and consultant paediatrician at the Mangla Hospital and Research Centre tweeted

Business TodayOver 800 new Covid cases in India; XBB 1.16 variant suspected to be driving the surgeOver 800 new Covid cases in India; XBB 1.16 variant suspected to be driving the surge. This variant is believed to be behind the recent surge in....1 day ago

<< Previous

Bullboard Posts

Next >>

High-quality lithium projects in Argentina with drilling underway